Study to assess the role of rifaximin in glycaemic control of poorly controlled diabetics. - Trial SLCTR_2018_004
Access comprehensive clinical trial information for SLCTR_2018_004 through Pure Global AI's free database. This Not Applicable trial is sponsored by Faculty of Medicine, University of Kelaniya and is currently Recruiting. The study focuses on Type 2 Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2018_004
Not Applicable
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2018_004
Study to assess the role of rifaximin in glycaemic control of poorly controlled diabetics.
Randomized Controlled Trial to assess effect of an additional short course of rifaximin compared to standard therapy alone for glycaemic control among poorly controlled diabetics
Study Focus
Interventional
Sponsor & Location
Faculty of Medicine, University of Kelaniya
Sri Lanka
Timeline & Enrollment
Not Applicable
May 16, 2018
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2018_004
Non-Device Trial